Sleep Disturbances and Their Association With Serum Magnesium Level in Patients With Major Depressive Disorder
NCT07198477 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2025-09-30
Summary
This cross-sectional study investigates the relationship between serum magnesium levels and the presence of sleep disturbances among patients with major depressive disorder (MDD).
Conditions
- Depressive Disorder
- Sleep Disturbances
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-30
- Primary Completion
- 2027-10-30
- Completion
- 2027-12-30
More Related Trials
-
Predictors of the Outcome of Late Life Depression
NCT02441387 ·Status: UNKNOWN
-
Cerebral Neuroinflammation During Major Depressive Episode
NCT03314155 ·Status: UNKNOWN ·Phase: NA
-
PET-MRI F-DOPA Activity in the Mesocorticolimbic System and Depressive Symptoms in the Prediction of Treatment Compatibility
NCT03026309 ·Status: UNKNOWN
-
Role of Magnesium Supplementation in the Treatment of Depression
NCT02466087 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Stress, Inflammation and Neuroimaging in Major Depressive Disorder as Compared to Premenstrual Dysphoric Disorder
NCT06130371 ·Status: RECRUITING
-
Assesment of Vitamin B6 Level in Patients With Major Depressive Disorder
NCT05649293 ·Status: NOT_YET_RECRUITING
-
Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms
NCT00844974 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging Study of Geriatric Depression
NCT00245557 ·Status: COMPLETED ·Phase: NA
-
Exploration of the Potential Mechanisms of n-3 Fatty Acids Supplementation in Depression and Cognitive Function in Patients With Late-life Depression
NCT05972798 ·Status: COMPLETED ·Phase: NA
-
Personalized, Predictive, Precise & Preventive Medicine for Major Depression
NCT06027177 ·Status: UNKNOWN
-
Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression
NCT00178087 ·Status: COMPLETED
-
The Relations Among Endotoxin, Inflammatory Cytokines, Cognitive Markers and Brain MRI Changes in Subjects With Depressive Disorder
NCT06203015 ·Status: RECRUITING
-
Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics
NCT03219008 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Cognitive-Oriented Intervention on Major Depressive Disorder
NCT05296174 ·Status: COMPLETED ·Phase: NA
-
MRI Studies of Emotion in Depression
NCT02429011 ·Status: COMPLETED
-
Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder
NCT01460212 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)
NCT07258485 ·Status: RECRUITING
-
Study of Sleep Inertia in Major Depressive Disorder by the Psychomotor Vigilance Task
NCT06732284 ·Status: RECRUITING
-
Apathy in Late Life Depression: New Biomarkers Using Actimetry and Magnetic Resonance Imaging
NCT03807167 ·Status: COMPLETED ·Phase: NA
-
Optimization of Diagnosis and Treatment of Depression Based on Multidimensional Clinical Assessment Classification
NCT04528628 ·Status: UNKNOWN ·Phase: NA
-
Psychological Burden of Anxiety and Depression Among Future Physicians: A Cross-sectional Study at Assiut University Faculty of Medicine
NCT07197125 ·Status: NOT_YET_RECRUITING
-
Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging
NCT01831440 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)
NCT03014544 ·Status: COMPLETED
-
Magnesium Sulfate Versus 5% Dextrose With Treatment Resistant Depression
NCT01597167 ·Status: COMPLETED ·Phase: NA
-
Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
NCT01428661 ·Status: COMPLETED ·Phase: PHASE2/PHASE3